Clinical Trials Directory

Trials / Unknown

UnknownNCT04260503

Gut Microbiome in Biliary Atresia

Analysis of Gut Microbiome and Liver Imaging Including Elasticity in Biliary Atresia Patients With Cholangitis for the Prediction of Disease Activity and Improvement of Outcome Using Fecal Microbiota Transplantation

Status
Unknown
Phase
Study type
Observational
Enrollment
36 (estimated)
Sponsor
Yonsei University · Academic / Other
Sex
All
Age
7 Years
Healthy volunteers
Accepted

Summary

The investigator will investigate the gut-microbiome and liver elasticity of the Biliary Atresia (BA)-patients before and after Kasai operation. The data will be analyzed according to their clinical outcomes including cholangitis to find out diagnostic makers, significantly associated with the BA-phenotypes. The decision-making tree for the BA will be updated with our data, which will strength the prognosis and prediction. The establishment of gut-liver axis, featured by cholangitis and gut-microbiome will open new pathway to treat the BA using fecal microbiota transplantation. 1. Analysis of gut-microbiome: The investigator will investigate the alteration of gut-microbiome by restoration of bile flow at diagnosis, before and after Kasai procedure. In case of cholangitis after Kasai operation, signature gut-microbiome will be analyzed, which will lead to prevention of BA-patients from cholangitis via the bacteria transplantation. 2. Analysis of elastography: In order to improve non-invasive diagnosis, The investigator will investigate the alteration of liver elasticity and hepatic blood flow before and after Kasai procedure as well as upon cholangitis and choledochal cyst. Those data will be analyzed in parallel with serum biochemical markers to be associated with pathophysiological events e.g., cholestasis, cholangitis and fibrosis.

Conditions

Interventions

TypeNameDescription
OTHERMonitoring of the gut-microbiome and ultrasound elasticity.The investigator will investigate the alteration of gut-microbiome and liver stiffness by restoration of bile flow by operation.
OTHERMonitoring of the gut-microbiomeThe investigator will investigate the alteration of gut-microbiome before and after operation.
OTHERMonitoring of the gut-microbiomeThe investigator will investigate the alteration of gut-microbiome along with the disease progress.
OTHERMonitoring of the gut-microbiome.The investigator will investigate the alteration of gut-microbiome according to the normal development.

Timeline

Start date
2019-05-21
Primary completion
2022-05-20
Completion
2022-05-20
First posted
2020-02-07
Last updated
2020-02-17

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04260503. Inclusion in this directory is not an endorsement.